OTC · QBIO
Healthcare · Biotechnology
$0.00
Up-$0.00 (+0.00%)
Updated Aug 23, 2026, 10:05 PM
SID Score
3.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
QBIO does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning QBIO.
QBIO research
Company profile and research snapshot.
Q BIOMED INC.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 29, 2018 | Roth Capital | Neutral | — |
| Jun 28, 2018 | Roth Capital | Buy | — |
No generated briefing is available yet.
defenseworld.net · Dec 10, 2025
Q Biomed (OTCMKTS:QBIO - Get Free Report) and SBC Medical Group (NASDAQ: SBC - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk. Earnings and Valuation This table compares Q
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning QBIO.
No results
No recent SID articles mention QBIO.
